Dubost-Brama A, Delaporte E, Catteau B, Warembourg A, Piette F, Bergoend H
Service de Dermatologie A, Hôpital Claude-Huriez, CHRU, Lille.
Ann Dermatol Venereol. 1997;124(8):540-3.
We report the first case of eosinophilic pustular folliculitis (Ofuji's disease) which was successfully treated with acitretin.
A 50-year old women (HIV negative) had developed over 3 months an erythematopapulous plaque under the left orbit. The clinical and histological diagnosis was eosinophilic pustular folliculitis. Successive treatment with cetirizine then indomethacin was ineffective. Acitretin (0.5 mg/kg/d) was then started and led to cure within 1 month. Six weeks after the patient spontaneously stopped the treatment, the lesion recurred at the same localization. Further treatment with isotretinoin (0.5 mg/kg/d) was then given but did not alter progression of the lesion. Acitretin was then reintroduced at the same dose and again produced rapid cure. Acitretin was then tapered off to 10 mg/d then maintained at this dose as lesions reappeared with further dose reduction.
It is difficult to treat eosinophilic pustular folliculitis because of the random nature of response to different drugs. General corticosteroids, dapsone and indomethacin are classically proposed but with variable success. Isotretinoin is proposed on the hypothesis of a link with sebaceous secretion, but results have been contradictory. This drug was ineffective in our case. Acitretin did however provide very rapid improvement with an efficacy confirmed at reintroduction. This retinoid which does not have the specific action of isotretinoin could affect follicular keratinocytes which have been shown to be activated in this chronic skin disease.
我们报告首例用阿维A成功治疗的嗜酸性脓疱性毛囊炎(Ofuji病)。
一名50岁女性(HIV阴性)在3个月内左眼眶下出现红斑丘疹性斑块。临床和组织学诊断为嗜酸性脓疱性毛囊炎。先后用西替利嗪和吲哚美辛治疗无效。随后开始使用阿维A(0.5mg/kg/天),1个月内治愈。患者自行停药6周后,原部位病变复发。随后给予异维A酸(0.5mg/kg/天)治疗,但未改变病变进展。然后再次以相同剂量重新使用阿维A,再次迅速治愈。随后将阿维A逐渐减量至10mg/天,随着剂量进一步减少病变再次出现,因此维持该剂量。
由于对不同药物反应的随机性,嗜酸性脓疱性毛囊炎难以治疗。经典的治疗药物有全身用糖皮质激素、氨苯砜和吲哚美辛,但疗效不一。基于与皮脂分泌有关的假设提出使用异维A酸,但结果相互矛盾。该药在我们的病例中无效。然而,阿维A确实能使病情迅速改善,再次使用时疗效得到证实。这种没有异维A酸特定作用的维甲酸可能会影响在这种慢性皮肤病中已被证明处于激活状态的毛囊角质形成细胞。